Min Jun

Associate Professor and Program Lead

University of New South Wales

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Min Jun is an Associate Professor and Program Lead at the University of New South Wales, Australia. His research focuses on cardiovascular and kidney disease, particularly the management of chronic conditions such as diabetes and the implementation barriers to evidence-based practices. Recent publications include studies on sodium-glucose cotransporter 2 inhibitors and clinical outcomes related to chronic kidney disease and cardiovascular events.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Richard O. Day

AUSTRALIA

View details

Michael O. Falster

AUSTRALIA

View details

Alys Havard

Associate Professor

AUSTRALIA

View details

Sophie Stocker

Senior Lecturer

University of Sydney

AUSTRALIA

View details

John Knight

Professorial Fellow

The George Institute for Global Health

AUSTRALIA

View details

Megumi Oshima

Kanazawa University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Min Jun

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?

Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management

Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study

Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial

Rethinking Models of Chronic Kidney Disease Care: A Narrative Review

Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes

Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data

Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study

Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial

The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor

Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study.

Therapy Escalation Following an Elevated HbA1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis

Collaborators (6)

Richard O. Day

Michael O. Falster

Alys Havard

Sophie Stocker

John Knight

Megumi Oshima

Make your next move.